FDA Drug Application (202121) for PROGESTERONE by TEVA PHARMS

Back to FDA Applications sponsored by TEVA PHARMS

Application Number202121
Product Number001
FormCAPSULE;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePROGESTERONE
Active IngredientPROGESTERONE

Active IngredientCount
List of drugs with Active Ingredient PROGESTERONE5


Back to FDA Applications sponsored by TEVA PHARMS